Categories: BiotechClinicalTrialsHealthcarePharmaTherapeutics
Crystalys Therapeutics is developing innovative therapies to transform the treatment of gout
Investors 1
Funding Rounds 1
Mentions in press and media 6
| Date | Title | Description |
| 27.07.2026 | Crystalys Therapeutics Inks $130 Million Series B |
SAN DIEGO, CA, Crystalys Therapeutics, a clinical-stage biopharmaceutical company, announced the closing of an oversubscribed $130 million Series B financing.
>> Click here for more funding data on Crystalys Therapeutics
>> To ... |
| 22.07.2026 | Venture capital & startup funding roundup, July 22, 2026: Andreessen Horowitz, Redpoint Ventures, Sequoia Capital, Insight Partners & more | If there was one clear signal in today’s funding landscape, it was that venture investors are no longer paying simply for “AI exposure.” They are paying for control points: endpoint security, military cyber operations, healthcare billing in... |
| 22.07.2026 | Crystalys Therapeutics Raises $130 Million To Bring Late-Stage Gout Drug To U.S. Market | Crystalys Therapeutics raises $130 million in an oversubscribed Series B financing round. The funding will help Crystalys take its late-stage gout drug to market. Series B comes less than a year after its impressive $205 million Series A of... |
| 22.07.2026 | Crystalys Therapeutics Raises $130M in Series B Funding | Crystalys Therapeutics, a San Diego, CA-based clinical-stage biopharmaceutical company, raised $130M in Series B funding.
The round was led by Frazier Life Sciences with participation from Wellington Management, HBM Healthcare Investments, ... |
| 30.09.2025 | Crystalys Therapeutics Raises in $205M Series A Funding | Crystalys Therapeutics, a San Diego, CA-based clinical-stage biopharmaceutical company, raised $205M in Series A funding.
The round was led by Novo Holdings, SR One and Catalys Pacific with participation from a broad syndicate of investors,... |
| - | Crystalys Therapeutics | “Crystalys Therapeutics - Passionate. Dedicated. We improve lives.” |
Reviews 0
